OBI Pharma, Inc. (TPEX:4174)
Taiwan · Delayed Price · Currency is TWD 56.90
-3.00 (-5.01%)
Oct 16, 2026, 1:30 PM CST
OBI Pharma Market Cap
OBI Pharma has a market cap or net worth of 7.49 billion as of October 16, 2026. It is the 19,946th most valuable company in the world and the 883rd biggest in Taiwan. Its market cap has increased by 5.45% in one year.
Market Cap
7.49B
Enterprise Value
8.14B
Revenue
52.20M
Global Rank
Country Rank
#883 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2012, OBI Pharma's market cap has decreased from 16.87B to 7.49B, a decrease of -55.61%. That is a compound annual growth rate of -5.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 7.49B | 5.45% |
| Dec 31, 2025 | 7.10B | -53.86% |
| Dec 31, 2024 | 15.39B | -3.28% |
| Dec 29, 2023 | 15.91B | 0.50% |
| Dec 30, 2022 | 15.83B | -30.20% |
| Dec 30, 2021 | 22.68B | -13.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TWi Biotechnology | 9.45B |
| Locus Cell | 8.71B |
| PharmaEngine | 8.25B |
| Tanvex BioPharma | 8.11B |
| Adimmune | 7.76B |
| Acepodia | 7.70B |
| Polaris Group | 7.48B |
| Savior Lifetec | 7.23B |